Oxycodone Hydrochloride Market Size, Share, Growth, Trends, and Forecast 2030

Oxycodone Hydrochloride Industry Perspective:    

The global oxycodone hydrochloride market size was evaluated at $401.63 million in 2022 and is slated to hit $578.94 million by the end of 2030 with a CAGR of nearly 4.66% between 2023 and 2030.

Request Free Sample

Oxycodone Hydrochloride Market: Overview

Oxycodone hydrochloride is a white and odorless crystalline powder that is extracted from opium alkaloids. According to NCBI, the oxycodone hydrochloride compound is obtained from the reaction of oxycodone with hydrochloric acid. For the record, it is an opioid analgesic that is used for providing relief to patients having moderate & severe pain. Furthermore, oxycodone hydrochloride possesses antitussive and analgesic properties. Moreover, oxycodone hydrochloride is recommended for patients who either do not respond to other pain therapies or the other non-opioid pain medicines prove to be ineffective in treating & relieving patients from pain.    

Key Insights

• As per the analysis shared by our research analyst, the global oxycodone hydrochloride market is projected to expand annually at the annual growth rate of around 4.66% over the forecast timespan (2023-2030)
• In terms of revenue, the global oxycodone hydrochloride market size was evaluated at nearly $401.63 million in 2022 and is expected to reach $578.94 million by 2030.
• The global oxycodone hydrochloride market is anticipated to record massive growth over the forecast period owing to an increase in the number of surgeries that has translated into the massive use of oxycodone hydrochloride as an analgesic opioid for patients to relieve them of pain.
• In terms of type, the controlled-release segment is slated to register the fastest CAGR over the analysis period.
• Based on the route of administration, the oral segment is predicted to lead the segmental surge over the forecast timeline.
• Region-wise, the Asia-Pacific oxycodone hydrochloride market is projected to register the highest CAGR during the assessment timeline.

Request Free Sample

Oxycodone Hydrochloride Market: Growth Factors

A rise in the number of surgeries globally can scoop the global market expansion

An increase in the number of surgeries has translated into the massive use of oxycodone hydrochloride as an analgesic opioid for patients to relieve them of pain. This will expand the scope of the growth of the oxycodone hydrochloride market across the globe. A surge in pain in the aging population prone to chronic disorders will further scale up the global market expansion. Moreover, the need for improvement in patient management activities and preference for pain-alleviating drugs in various healthcare establishments such as hospitals, ambulatory surgical centers, and specialty clinics will prompt global market trends. New product launches is one of the key business strategy adopted by business players for churning massive profits. Moreover, such moves are likely to account for the major growth of the market sphere across the globe. For instance, in July 2022, Kowa Pharmaceuticals America, Inc., a key U.S.-based firm focusing on developing anti-inflammatory medicines, launched SEGLENTIS®, an opioid agonist & anti-inflammatory drug used for treating patients having acute pain. The move is likely to provide impetus to the production and use of oxycodone hydrochloride in the coming years.  

Oxycodone Hydrochloride Market: Restraints

Depressive effects created due to analgesic features of drugs can impede the global industry expansion

The product creates a depressive effect in the medulla and can even cause sedation, constipation, euphoria, respiratory issues, anxiolysis, and miosis in individuals. All these aforementioned factors can hinder the expansion of the global oxycodone hydrochloride industry to some extent in the long run.    

Oxycodone Hydrochloride Market: Opportunities

Growing product preference for treating chronic ailments can create new growth opportunities for the global industry

A rise in the product prescription by physicians for treating pain in patients will open new growth avenues for the global oxycodone hydrochloride market. Apart from this, a rise in the demand for medicine post surgeries to relieve patients from acute pain will further shape the growth of the market globally.

Oxycodone Hydrochloride Market: Challenges

Stringent government regulations pertaining to the use of drugs in EU and North American countries can be a big challenge for the global industry surge

Strict government laws related to the prescription and use of the drug for alleviating pain in patients are poised to be a big challenge for the global oxycodone hydrochloride industry expansion in the forthcoming years. Various side effects occurring due to the intake of these medicines can further challenge the growth of the industry globally in the years ahead.

Oxycodone Hydrochloride Market: Segmentation

The global oxycodone hydrochloride market is sectored into type, route of administration, distribution channel, and region.  

In type terms, the global oxycodone hydrochloride market is segregated into controlled-release and immediate-release segments. In addition to this, the controlled release segment, which garnered nearly 55% of the global market share in 2022, is projected to record the highest CAGR in the ensuing years. The growth of the segment in the ensuing years can be due to the ability to control the release of oxycodone hydrochloride medicines for relieving moderate and severe pain in patients. Moreover, the controlled release of the medicine is preferred owing to the growing misuse, diversion, and abuse of oxycodone hydrochloride. Additionally, the growing preference for the controlled release of oxycodone hydrochloride drug over the immediate release of the drug for treating pain in cancer patients will further boost the segmental expansion.

Based on route of administration, the global oxycodone hydrochloride industry is bifurcated into oral and parenteral segments. In addition to this, the oral segment, which contributed remarkably towards the global industry share in 2022, is set to establish a dominant position in the global industry in the years to come. The segmental expansion over the assessment timeline can be due to the rise in the administration of oxycodone hydrochloride medicines in oral form in cancer patients for curing pain in these patients.

On the basis of distribution channel, the global oxycodone hydrochloride market is divided into hospitals and retail pharmacies segments.

Oxycodone Hydrochloride Market: Report Scope

Oxycodone Hydrochloride Market: Regional Insights

North America is likely to establish a numero uno position in the global market over 2023-2030

North America, which accounted for half of the global oxycodone hydrochloride market share in 2022, will be the leading region during the assessment period. Moreover, the growth of the regional market over the anticipated timeline can be subject to a rise in the prescription of the drug for treating moderate & severe pain resulting from arthritis, bursitis, cancer, and neuralgia in countries such as the U.S. Reportedly, the U.S. FDA has approved the drug for effectively managing pain. Additionally, the presence of key pharmaceutical firms such as Merck & Co Inc., Pfizer, Inc., Amgen Inc., and EVERSANA in the U.S. will contribute majorly towards the regional market trends.

The Asia-Pacific oxycodone hydrochloride industry is set to register the highest CAGR over the forecast timeframe owing to the presence of a large patient population pool suffering from chronic ailments and in need of reducing pain. Apart from this, liberal laws in the emerging economies of the region towards the use of the drug for treating moderate to severe pain will further enlarge the scope of the demand for oxycodone hydrochloride in the sub-continent. Furthermore, countries such as China and India are slated to be the key regional revenue pockets in the upcoming years.  

Oxycodone Hydrochloride Market: Competitive Space

The global oxycodone hydrochloride market profiles key players such as:

• Eli Lilly and Co.
• Gilead Sciences Inc.
• Manus Aktteva Biopharma LLP
• Arevipharma
• Saneca Pharma
• Cipla Ltd
• Noramco
• Macfarian Smith
• Teva Pharmaceutical Industries Ltd
• Taj Pharma
• Chattem Chemicals Inc.
• Mayne Pharma Group Limited
• Dr. Reddy's Laboratories Ltd
• Siegfried
• Rhodes Pharmaceuticals
• Mallinckrodt Plc
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Sun Pharmaceutical Industries Ltd
• Lupin Ltd
• Sanofi Sais

The global oxycodone hydrochloride market is segmented as follows:

By Type

• Controlled-Release
•  Immediate-Release

By Route of Administration

• Oral
• Parenteral

By Distribution Channel

• Hospitals
• Retail Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa